CLIFF (Cordlife Group) Tariff Resilience Score: 4/10 (As of Jun. 29, 2026)


CLIFF Cordlife Group Ltd CLIFF
33 GF Score
Price $0.15
GF Value $0.20
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Cordlife Group Tariff Resilience Score?

Cordlife Group CLIFF 33 Tariff Resilience Score is 4 as of Jun. 29, 2026. GuruFocus rates CLIFF with a GF Score™ of 33/100 and a GF Value™ of $0.20 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 215 Medical Diagnostics & Research companies, Cordlife Group ranks better than 69.3% on this metric.

Cordlife Group has the Tariff Resilience Score of 4, which implies that the company might have Average Resilient.

Cordlife Group has CLIFF operates in healthcare with international exposure. Tariffs on medical equipment and supplies could impact costs. The company has limited pricing power and few alternative suppliers.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Cordlife Group might have Average Resilient.

Cordlife Group  (OTCPK:CLIFF) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Cordlife Group Tariff Resilience Score Related Terms

CLIFF vs TMO, DHR, IDXX: Tariff Resilience Score Comparison

For the Diagnostics & Research subindustry, Cordlife Group's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cordlife Group Tariff Resilience Score vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Cordlife Group's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Cordlife Group's Tariff Resilience Score falls into.


CLIFF
33GF Score
Cordlife Group Ltd CLIFF
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 4 mean?
Cordlife Group (CLIFF) has a Tariff Resilience Score of 4 as of Jun. 29, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Cordlife Group ranks #66 out of 215 companies in the Medical Diagnostics & Research industry, placing it in the top 30.7%.
Is Cordlife Group's Tariff Resilience Score too high?
Cordlife Group's current Tariff Resilience Score is 4. Based on the distribution chart, Cordlife Group ranks #66 out of 215 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Cordlife Group has a GF Score™ of 33/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Cordlife Group's Tariff Resilience Score compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Cordlife Group ranks #66 out of 215 companies for Tariff Resilience Score. This puts Cordlife Group in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Medical Diagnostics & Research company?
A good Tariff Resilience Score depends on the Medical Diagnostics & Research industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. Cordlife Group's current Tariff Resilience Score is 4. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cordlife Group stock overvalued right now?
Based on GuruFocus' analysis, Cordlife Group (CLIFF) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.20, compared to a current price of $0.15 — trading 24.8% below its estimated fair value. The current Tariff Resilience Score is 4. Cordlife Group's overall GF Score™ is 33/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Cordlife Group (CLIFF), the current Tariff Resilience Score is 4 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cordlife Group (CLIFF) Overvalued in 2026?

Based on GuruFocus' analysis, Cordlife Group stock appears to be undervalued. The current stock price of $0.15 is trading 24.8% below its estimated GF Value™ of $0.20. GuruFocus considers Cordlife Group to be Modestly Undervalued.

Key valuation signals for CLIFF:

  • Tariff Resilience Score: 4
  • GF Value™: $0.20 vs. price of $0.15 (24.8% below fair value)
  • GF Score™: 33/100 with 4 warning signs

No single metric tells the full story. See the CLIFF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cordlife Group Business Description

Other Exchanges P8A:Singapore
Address 1 Kim Seng Promenade, No. 15-01, Great World City East, Singapore, SGP, 237994
Cordlife Group Ltd is a consumer healthcare company dedicated to safeguarding the well-being of mother and child. Along with its subsidiaries, the company is engaged in the provision of diagnostics and cord blood banking services, which involve the processing and storage of cord blood stem cells. The group has two reportable segments as follows: the Banking segment, which derives maximum revenue, comprises the collection, processing, and banking of biological materials; and the Diagnostics segment, which comprises diagnostics testing services. Geographically, the group generates maximum revenue from Hong Kong, and the rest from the Philippines, India, Malaysia, Singapore, and other regions.
33GF Score

Get the complete analysis for CLIFF

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.15
Price
$0.20
GF Value